We apologize for the inconvenience

The people search feature on Superpages.com is temporarily unavailable. You can still search for people on yellowpages.com since Yellow Pages and Superpages are part of one company.

You will be automatically re-directed to People Search on yellowpages.com in .

Please note our privacy policy has changed. To view the policy, please go to https://corporate.thryv.com/privacy/

Details

General Info

Cystic Fibrosis Research, Inc ( CFRI ) is a 501 ( c ) ( 3 ) nonprofit organization, founded in 1975. Our MissionCFRI's mission is to fund research, provide educational and personal support, and spread awareness of cystic fibrosis ( CF ), a life-threatening genetic disease.Our Services:Led by our Board of Directors and a dedicated staff, our many committed volunteers provide the CF community with a wide range of resources and services. Our committees include:The Research Advisory Committee ( RAC ), whose volunteer members include physicians, scientists, and community members. The Research Advisory Committee administers, reviews and offers guidance on what cystic fibrosis research to fund. Currently they are administering the Elizabeth Nash Memorial Post-Doctoral Fellowship and the New Horizons Research Campaign.The Events Committees, which organize and coordinate many popular events throughout the year. These include the Educational Conference, the Day Retreat, the Golf Tournament, and the Mothers' Day Tea.The Newsletter Committee, which produces our award-winning monthly newsletter, with over 15, 000 subscribers.

HoursOPEN NOW
Regular Hours:
Mon - Fri

Contact Info

Phones:

Main - 650-665-7559

Fax - 650-404-9981

ExtraTollFree - 855-237-4669

Extra - 650-404-9975

Address:
1731 Embarcadero Rd Ste 210 Palo Alto, CA 94303
Email:

Reviews

Be the first to review!
Write a Review
Category
Research Services
Payment Options
amex, discover, master card, paypal, visa
Suggest an Edit
Are you the business owner?Claim This Business
Data provided by one or more of the following: Thryv, Data Axle, Yext.